Ramon L. Corbalan
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry.
Journal: The American journal of medicine
Published: July 31, 2023
Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study.
Journal: Journal of cardiac failure
Published: April 20, 2023
Targeting VCAM-1: a therapeutic opportunity for vascular damage.
Journal: Expert opinion on therapeutic targets
Published: March 07, 2023
Gliflozins and Atrial Fibrillation.
Journal: Journal of the American College of Cardiology
Published: August 19, 2022
Atrial fibrillation, an arrhythmia and a syndrome
Journal: Revista medica de Chile
Published: July 27, 2022
Optimizing Treatment for Acute Myocardial Infarction, a Continuous Effort.
Journal: Arquivos brasileiros de cardiologia
Published: May 25, 2022
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
Journal: European heart journal
Published: September 16, 2021
VCAM-1 as a predictor biomarker in cardiovascular disease.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 27, 2021
Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF.
Journal: American heart journal
Published: November 17, 2020
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
Journal: The New England journal of medicine
Published: November 13, 2020
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials.
Journal: European journal of heart failure
Published: August 29, 2020
Last Updated: 09/26/2026